This FTSE 100 stock looks like a fantastic dip buy to me

Royston Wild looks at a brilliant FTSE 100 (INDEXFTSE: UKX) company for contrarian stock selectors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investor demand for Associated British Foods (LSE: ABF) has been pretty thin on the ground in recent weeks.

Since hitting 18-month highs above £33.70p per share back in October, the Primark owner’s share price has been locked in a heavy downtrend and it has shed almost a fifth of its value since then.

Stock pickers have taken fright at the clear decline in retail conditions since the start of the autumn (just today researcher GfK announced that consumer confidence slumped to a four-year low of -13 in December, causing plenty of concern for Britain’s retail sector as we enter 2018).

But rather than sink in the current climate, I reckon ABF’s profits could thrive. I see current weakness as a prime buying opportunity.

Primark powers on

Full-year financials released in November certainly didn’t smack of a business in distress. At actual currencies the FTSE 100 firm saw revenues rise 15% in the 12 months to September, to £15.4bn, or 6% at constant exchange rates. As a result, adjusted pre-tax profit rose 22% to £1.31bn. And there is plenty of reason to expect turnover to keep on booming.

The rising pressure on shoppers’ wallets saw sales at its low-cost Primark stores in the UK rise 10% year-on-year, the company noting that its share of the market grew “significantly” in the period. UBS estimates that the chain commands just 15% of the British clothing market, leaving plenty of room for further growth.

And of course, expansion in Europe and the US also creates splendid revenues opportunities in the years ahead (sales at Primark leapt 16% in Continental Europe in the last year).

City analysts do not expect the troubles on the high street to put paid to future earnings expansion, and are predicting a 7% bottom line improvement during fiscal 2018.

And in this environment, it is expected to keep lifting dividends at a rapid rate. The company lifted the full-year payout 12% last year, to 41p per share, and another hefty hike — to 44.7p — is predicted for the current year. This yields a very handy 1.6%.

Investors may consider a forward P/E ratio of 20.6 times too expensive, but in my opinion ABF is worthy of such a premium rating given the brilliant growth opportunities over at Primark, not to mention the brighter outlook for its Sugar division.

Tech titan

Sophos Group (LSE: SOPH) is another great growth share that has been on the back foot more recently. Its market value has dipped 15% since punching record peaks of 646p per share just a month ago following a share placing.

Demand for the online security specialist’s services continues to strengthen, the business witnessing a 22% jump in billings between April and September (and 29% in the final three months of the period), and 280,000 more clients added during the period.

And this growth is broad based too, Sophos reporting double-digit percentage sales across all of its major regions.

With sales steadily taking off, the City is expecting the FTSE 250 firm to bounce from a 63% earnings decline in the year to March 2018 — the third drop in a row if realised — with a 133% improvement next year.

A forward P/E ratio of 100.3 times may be too rich for many investors, although a sub-PEG reading of 0.8 suggests Sophos is actually attractively priced relative to its growth prospects.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »